Dr Amanda Wade
Post-Doc
Working groups
Background
Amanda is an infectious diseases physician who completed advanced training at The Alfred and Geelong Hospitals. Since obtaining her fellowship, she has worked at Barwon Health and taught at Deakin University.
Amanda has an interest in blood-borne viruses and sexually transmitted infections, and has been working in the sexual health and liver clinics at Barwon Health for some years. Recently she started managing the liver clinic, which provides viral hepatitis services to the area.
She was awarded her PhD in 2018 after investigating models of care for hepatitis C in the era of directly-acting antivirals. Professor Margaret Hellard AM was her primary supervisor.
Amanda's goal is to increase hepatitis C service provision for those in regional and rural areas.
Qualifications
- 2018: PhD
- 2008: FRACP (Infectious Diseases)
- 1999: MBBS (Hons), Monash
Awards
2022: LiverWELL Recognition Award - Individual Contribution
Positions
- Director, Liver clinic, Barwon Health
- Infectious diseases physician, Barwon Health
Burnet publications
View 29 moreKnowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research
Journal of Viral Hepatitis
Marvad Ahad et al
Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial
Journal of Viral Hepatitis
Katherine Heath et al
One size does not fit all: healthcare worker perspectives on hepatitis B models of care in a low-prevalence region in Australia
Australian and New Zealand Journal of Public Health
Joshua Richmond et al
Reports and other work
-
World-first study shows the benefits of treating hepatitis C in primary care
Providing hepatitis C treatment in the primary care setting increases both treatment uptake and cure: the Prime Study.
World-first study shows the benefits of treating hepatitis C in primary care -
Improving general practitioners' knowledge of hepatitis C care
General practitioners' knowledge of hepatitis C care has increased over time, yet many are unsure whether people who inject drugs are eligible for hepatitis C treatment.
Improving general practitioners' knowledge of hepatitis C care -
Resources are required to support management of hepatitis C in general practice
A Burnet survey undertaken in 2016 showed that although many general practitioners are interested in treating hepatitis C, further resources are needed to optimise treatment in primary care.
Resources are required to support management of hepatitis C in general practice
-
Evidence supports community-based hepatitis C care
Compared to tertiary-based hepatitis C care, community-based care increases treatment uptake whilst maintaining cure outcomes.
Evidence supports community-based hepatitis C care -
Collaborative approach in primary care increases access to hepatitis C treatment in a regional area
Implementation of a remote consultation pathway facilitates interaction between general practitioners and tertiary healthcare services to improve hepatitis C service delivery.
Collaborative approach in primary care increases access to hepatitis C treatment in a regional area
